Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis-Reference-Cited by-同舟云学术

Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis

Published:2016 Issue:2 Volume:1 Page:e000038
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Orditura Michele,Galizia Gennaro,Diana Anna,Saccone Ciro,Cobellis Luigi,Ventriglia Jole,Iovino Francesco,Romano Ciro,Morgillo Floriana,Mosca Lavinia,Diadema Maria Rosaria,Lieto Eva,Procaccini Eugenio,De Vita Ferdinando,Ciardiello Fortunato

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference46 articles.

1. Globocan 2012. Fast Stats.Most frequent cancers: both sexes. http://globocan.iarc.fr/old/bar_sex_site_prev.asp?selection=3152&title=Breast&statistic=3&populations=6&window=1&grid=1&color1=5&color1e=&color2=4&color2e=&submit=%C2%A0Execute%C2%A0 (accessed 12 Sep 2015).

2. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials;Peto;Lancet,2012

3. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Davies;Lancet,2011

4. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2011

5. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Senkus;Ann Oncol,2015

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil–lymphocyte ratio reflects tumour‐infiltrating lymphocytes and tumour‐associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapy;Histopathology;2024-01-09

2. The effects of dexmedetomidine on postoperative tumor recurrence and patient survival after breast cancer surgery: a feasibility study;Anesthesiology and Perioperative Science;2023-11-24

3. Proposing a novel molecular subtyping scheme for predicting distant recurrence-free survival in breast cancer post-neoadjuvant chemotherapy with close correlation to metabolism and senescence;Frontiers in Endocrinology;2023-10-12

4. Emodin reduces surgical wounding‐accelerated tumor growth and metastasis via macrophage suppression in a murine triple‐negative breast cancer model;Physiological Reports;2023-10

5. Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance;Breast Cancer Research;2023-07-26